The International Pharma Federation (IPF) arranged a pharmaceutical conference on 23 January 2026 at Hotel KC Cross Roads, Sector 10, Panchkula, Haryana, to support pharmaceutical entrepreneurs and to develop their business operations through existing ecosystem improvements. More than 300 pharmaceutical companies from across the country participated. The pharmaceutical industry plays a crucial role in society. Its impact goes beyond factories and medicine production, focusing on providing safe healthcare and earning public trust. In India, hundreds of small and medium-sized companies work daily to deliver quality medicines to patients. This conference functioned as more than an ordinary meeting. The event brought together MSME (Micro, Small & Medium Enterprises) pharma entrepreneurs, drug department officials, industry experts & IPF leadership under one roof. The Goal was Simple yet Meaningful Enhance the industry’s image through strict compliance, transparency, and ethical business practices. International Pharma Federation (IPF) The International Pharma Federation IPF functions as a unified organisation that protects and supports all pharmaceutical enterprises across the Micro, Small & Medium Enterprise (MSME) sector. IPF establishes a connection between three parties: Pharma businesses Regulatory authorities Industry experts Young & upcoming entrepreneurs The IPF organisation emphasises that business development must occur alongside regulatory compliance. A strong pharma industry requires companies to abide by regulations that safeguard patients and create employment opportunities while making valuable contributions to their home countries. IPF uses conferences, awareness programs, training sessions, and discussions to accomplish its goal of educational programs for pharma entrepreneurs, which feature information about ethical business practices, regulatory compliance details, and activities that will enhance pharma industry public relations work. The Panchkula Conference: A National Gathering of Pharma MSMEs The Panchkula conference saw broad attendance from entrepreneurs nationwide, drawing participants from many states to engage in key industry discussions. The event achieved greater significance because senior executives from the drug department attended as guests. Their participation demonstrated that regulators and industry can work together, rather than against each other. The conference program covered: All essential pharma matters received discussion. All practical information was distributed to attendees. The program created incentives for young entrepreneurs to develop their skills. The team assigned to this project focused on achieving compliance standards while maintaining top-quality assurance. The industry benefits from this type of interaction because it establishes trust, transparency, and industry confidence. Opening Remarks by the President: Setting the Right Direction The IPF leadership delivered their opening statements, which created a professional atmosphere that lasted through the conference. The statement emphasised that:- Pharma MSMEs are not weak players. The organisations maintain their obligations to both healthcare and employment. The organisations need to be treated with respect through transparent communication and equitable treatment. The leadership showed that pharma entrepreneurship requires difficult work, yet entrepreneurs can achieve ethical success through proper support and guidance. Redefining PCD: From Perception to Purpose PCD Means Pharma Channel Development The conference’s main demonstration established IPF as its central organisation, which maintains unambiguous support for PCD. IPF officially presented PCD as “Pharma Channel Development”, not as a negative or misleading concept. Statement by IPF Spokesperson – Mr Surender Rathi Mr Surender Rathi clearly stated: “We follow the same compliance standards as other pharmaceutical companies. We also provide quality medicines to patients. We should not be linked with misleading labels like ‘propaganda’. We are partners in progress & contribute to employment for over 2 lakh people across India. Any attempt to weaken us is unacceptable.” Why Was This Clarification Necessary? The PCD model has been misunderstood by certain groups for several years. IPF clarified that: PCD companies operate under identical legal and regulatory frameworks The organisation maintains all required quality standards. All documentation requirements, plus storage needs, plus marketing obligations, plus compliance duties must be fulfilled. PCD functions as a support system for delivering medicines to their final destinations The program creates numerous job opportunities throughout its operations. The presence of senior drug department officials showed that regulation is about guidance, not harassment. Key Knowledge Sessions & Learnings 1.New SOPs in Manufacturing & Marketing Speaker: Mr. Sushant Sharma (CDSCO – North Zone) Mr Sharma shared insights on: Updated SOPs (Standard Operating Procedures) Best practices in manufacturing Responsible marketing methods Documentation and traceability His session helped entrepreneurs understand that strong SOPs protect both business and patients. 2. Pharma Protocol Quiz: Learning Through Engagement Speaker: Mr Lalit Goyal (Haryana State Drug Controller) Mr Goyal organised a pharma protocols quiz for young entrepreneurs, which used interactive teaching methods. The session achieved three objectives, which included: Improved understanding of regulatory matters Encouraged active participation from attendees Made learning simple & Practical The study found that people can understand that regulatory knowledge does not have to be difficult. 3. Preventing Drug Misuse Speaker: Mr Sanjeev Garg (Drug Controller, Punjab) Mr Garg highlighted: Campaigns to prevent drug abuse Importance of responsible distribution Role of pharma companies in public safety This session reminded everyone that business success should never come at the cost of public health. 4. Storage & Expiry Management Speaker: Mr Ripan Mehta Mr Mehta delivered an energetic and practical talk on: Proper storage conditions Temperature control Expiry management Stock rotation He explained in simple terms that: A good medicine can become a bad medicine if stored incorrectly. 5. Support Systems for Pharma Companies Speaker: Mr Amit Duggal Mr Duggal spoke about: Financial support Industry resources Advisory systems Growth support mechanisms This session gave confidence to MSMEs that help and systems are available if approached correctly. Special Guests Who Strengthened the Event The event was honoured by the presence of: Mr Praveen Kumar (DCO Panchkula) Mr. Amit Lakhanpal Mr Tajinder Singh (Drug Inspector, Chandigarh) Their presence reinforced the message that regulators and industry are partners, not enemies. Leadership & Team IPF:… Continue reading International Pharma Federation (IPF): Building a Responsible & Progressive Pharma Ecosystem
